Tagged With Amgen

Buy these 3 stocks as they move above key resistance levels, Bank of America says


Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it's part of a plan to get Celgene's mega-merger with Bristol-Myers Squibb approved


Earnings season rages on this week. Here are the 8 companies to watch — and what to look out for.



Dispensed: Venture-backed insurance startup Bright Health's 2018 results, a dispute between 2 drug giants, and the quest for a male birth control drug


Drugmakers are using an unusual tactic to compete in a new class of medication treating the 38 million Americans who have migraines


A new migraine medication that's changing the way we treat a condition that affects 38 million Americans just got approved



The FDA just approved a new kind of medication that could change the way migraine patients are treated


Allergan just got one step closer to approval for its migraine drug -- and it's part of a wave of new treatments for the condition that affects 38 million Americans


The FDA just approved the first direct competitor to a billion-dollar cancer drug


There's a race to treat a condition that affects 38 million Americans -- here's what you need to know


This first-of-its-kind cancer treatment is only the beginning


The FDA just approved a treatment that uses a modified herpes virus to treat cancer



A new set of drugs could revolutionise the never-ending battle against high cholesterol -- but there's a huge catch